Skip to main content
Market intelligence
ANIXHealthcare

Anixa Biosciences Inc insider activity

In the last 90 days, 2 corporate insiders purchased $59,987 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$59,987
Corporate buyers
2
Latest transaction
Jun 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 16, 2026Lewis H Titterton jrCorporate insiderOpen Market Purchase2,836$2.64$7,487
Jun 12, 2026Amit KumarChief Executive OfficerOpen Market Purchase21,000$2.50$52,500